BioCentury
ARTICLE | Clinical News

Feraccru ferric maltol regulatory update

February 9, 2015 8:00 AM UTC

Shield said EMA accepted for review an MAA for oral Feraccru ferric maltol to treat iron deficiency anemia in patients with inflammatory bowel disease (IBD) and those intolerant of oral ferrous therap...